| Genasense (oblimersen) / Genta |
NCT00091078: Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery |
|
|
| Terminated | 2a | 96 | US | oblimersen sodium, augmerosen, G3139, G3139 bcl-2 antisense oligodeoxynucleotide, Genasense, imatinib mesylate, CGP 57148, Gleevec, Glivec, laboratory biomarker analysis | National Cancer Institute (NCI) | Gastrointestinal Stromal Tumor | 07/06 | | | |
NCT00047229: Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) |
|
|
| Completed | 2 | 27 | Canada | oblimersen sodium, doxorubicin hydrochloride | University Health Network, Toronto, National Cancer Institute (NCI) | Liver Cancer | 01/09 | 04/09 | | |
NCT00003103: Chemotherapy in Treating Patients With Solid Tumors |
|
|
| Completed | 1/2 | 57 | US | oblimersen sodium, docetaxel | Memorial Sloan Kettering Cancer Center | Bladder Cancer, Breast Cancer, Colorectal Cancer, Esophageal Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Ovarian Cancer, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific | 08/02 | 08/02 | | |
NCT00004870: Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer |
|
|
| Completed | 1/2 | | US | oblimersen sodium, irinotecan hydrochloride | The University of Texas Health Science Center at San Antonio, National Cancer Institute (NCI) | Colorectal Cancer | 09/02 | 09/02 | | |
NCT00055822: Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer |
|
|
| Completed | 1/2 | 16 | US | oblimersen sodium, fluorouracil, leucovorin calcium, oxaliplatin | The University of Texas Health Science Center at San Antonio, National Cancer Institute (NCI) | Colorectal Cancer | 10/04 | 10/04 | | |
